Cargando…

Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition

[Image: see text] Three new thiosemicarbazones (TSCs) HL(1)–HL(3) as triapine analogues bearing a redox-active phenolic moiety at the terminal nitrogen atom were prepared. Reactions of HL(1)–HL(3) with CuCl(2)·2H(2)O in anoxic methanol afforded three copper(II) complexes, namely, Cu(HL(1))Cl(2) (1),...

Descripción completa

Detalles Bibliográficos
Autores principales: Besleaga, Iuliana, Stepanenko, Iryna, Petrasheuskaya, Tatsiana V., Darvasiova, Denisa, Breza, Martin, Hammerstad, Marta, Marć, Małgorzata A., Prado-Roller, Alexander, Spengler, Gabriella, Popović-Bijelić, Ana, Enyedy, Eva A., Rapta, Peter, Shutalev, Anatoly D., Arion, Vladimir B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335727/
https://www.ncbi.nlm.nih.gov/pubmed/34279079
http://dx.doi.org/10.1021/acs.inorgchem.1c01275
_version_ 1783733182092279808
author Besleaga, Iuliana
Stepanenko, Iryna
Petrasheuskaya, Tatsiana V.
Darvasiova, Denisa
Breza, Martin
Hammerstad, Marta
Marć, Małgorzata A.
Prado-Roller, Alexander
Spengler, Gabriella
Popović-Bijelić, Ana
Enyedy, Eva A.
Rapta, Peter
Shutalev, Anatoly D.
Arion, Vladimir B.
author_facet Besleaga, Iuliana
Stepanenko, Iryna
Petrasheuskaya, Tatsiana V.
Darvasiova, Denisa
Breza, Martin
Hammerstad, Marta
Marć, Małgorzata A.
Prado-Roller, Alexander
Spengler, Gabriella
Popović-Bijelić, Ana
Enyedy, Eva A.
Rapta, Peter
Shutalev, Anatoly D.
Arion, Vladimir B.
author_sort Besleaga, Iuliana
collection PubMed
description [Image: see text] Three new thiosemicarbazones (TSCs) HL(1)–HL(3) as triapine analogues bearing a redox-active phenolic moiety at the terminal nitrogen atom were prepared. Reactions of HL(1)–HL(3) with CuCl(2)·2H(2)O in anoxic methanol afforded three copper(II) complexes, namely, Cu(HL(1))Cl(2) (1), [Cu(L(2))Cl] (2′), and Cu(HL(3))Cl(2) (3), in good yields. Solution speciation studies revealed that the metal-free ligands are stable as HL(1)–HL(3) at pH 7.4, while being air-sensitive in the basic pH range. In dimethyl sulfoxide they exist as a mixture of E and Z isomers. A mechanism of the E/Z isomerization with an inversion at the nitrogen atom of the Schiff base imine bond is proposed. The monocationic complexes [Cu(L(1–3))](+) are the most abundant species in aqueous solutions at pH 7.4. Electrochemical and spectroelectrochemical studies of 1, 2′, and 3 confirmed their redox activity in both the cathodic and the anodic region of potentials. The one-electron reduction was identified as metal-centered by electron paramagnetic resonance spectroelectrochemistry. An electrochemical oxidation pointed out the ligand-centered oxidation, while chemical oxidations of HL(1) and HL(2) as well as 1 and 2′ afforded several two-electron and four-electron oxidation products, which were isolated and comprehensively characterized. Complexes 1 and 2′ showed an antiproliferative activity in Colo205 and Colo320 cancer cell lines with half-maximal inhibitory concentration values in the low micromolar concentration range, while 3 with the most closely related ligand to triapine displayed the best selectivity for cancer cells versus normal fibroblast cells (MRC-5). HL(1) and 1 in the presence of 1,4-dithiothreitol are as potent inhibitors of mR2 ribonucleotide reductase as triapine.
format Online
Article
Text
id pubmed-8335727
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-83357272021-08-05 Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition Besleaga, Iuliana Stepanenko, Iryna Petrasheuskaya, Tatsiana V. Darvasiova, Denisa Breza, Martin Hammerstad, Marta Marć, Małgorzata A. Prado-Roller, Alexander Spengler, Gabriella Popović-Bijelić, Ana Enyedy, Eva A. Rapta, Peter Shutalev, Anatoly D. Arion, Vladimir B. Inorg Chem [Image: see text] Three new thiosemicarbazones (TSCs) HL(1)–HL(3) as triapine analogues bearing a redox-active phenolic moiety at the terminal nitrogen atom were prepared. Reactions of HL(1)–HL(3) with CuCl(2)·2H(2)O in anoxic methanol afforded three copper(II) complexes, namely, Cu(HL(1))Cl(2) (1), [Cu(L(2))Cl] (2′), and Cu(HL(3))Cl(2) (3), in good yields. Solution speciation studies revealed that the metal-free ligands are stable as HL(1)–HL(3) at pH 7.4, while being air-sensitive in the basic pH range. In dimethyl sulfoxide they exist as a mixture of E and Z isomers. A mechanism of the E/Z isomerization with an inversion at the nitrogen atom of the Schiff base imine bond is proposed. The monocationic complexes [Cu(L(1–3))](+) are the most abundant species in aqueous solutions at pH 7.4. Electrochemical and spectroelectrochemical studies of 1, 2′, and 3 confirmed their redox activity in both the cathodic and the anodic region of potentials. The one-electron reduction was identified as metal-centered by electron paramagnetic resonance spectroelectrochemistry. An electrochemical oxidation pointed out the ligand-centered oxidation, while chemical oxidations of HL(1) and HL(2) as well as 1 and 2′ afforded several two-electron and four-electron oxidation products, which were isolated and comprehensively characterized. Complexes 1 and 2′ showed an antiproliferative activity in Colo205 and Colo320 cancer cell lines with half-maximal inhibitory concentration values in the low micromolar concentration range, while 3 with the most closely related ligand to triapine displayed the best selectivity for cancer cells versus normal fibroblast cells (MRC-5). HL(1) and 1 in the presence of 1,4-dithiothreitol are as potent inhibitors of mR2 ribonucleotide reductase as triapine. American Chemical Society 2021-07-19 2021-08-02 /pmc/articles/PMC8335727/ /pubmed/34279079 http://dx.doi.org/10.1021/acs.inorgchem.1c01275 Text en © 2021 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Besleaga, Iuliana
Stepanenko, Iryna
Petrasheuskaya, Tatsiana V.
Darvasiova, Denisa
Breza, Martin
Hammerstad, Marta
Marć, Małgorzata A.
Prado-Roller, Alexander
Spengler, Gabriella
Popović-Bijelić, Ana
Enyedy, Eva A.
Rapta, Peter
Shutalev, Anatoly D.
Arion, Vladimir B.
Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition
title Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition
title_full Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition
title_fullStr Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition
title_full_unstemmed Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition
title_short Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition
title_sort triapine analogues and their copper(ii) complexes: synthesis, characterization, solution speciation, redox activity, cytotoxicity, and mr2 rnr inhibition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335727/
https://www.ncbi.nlm.nih.gov/pubmed/34279079
http://dx.doi.org/10.1021/acs.inorgchem.1c01275
work_keys_str_mv AT besleagaiuliana triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT stepanenkoiryna triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT petrasheuskayatatsianav triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT darvasiovadenisa triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT brezamartin triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT hammerstadmarta triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT marcmałgorzataa triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT pradorolleralexander triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT spenglergabriella triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT popovicbijelicana triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT enyedyevaa triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT raptapeter triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT shutalevanatolyd triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition
AT arionvladimirb triapineanaloguesandtheircopperiicomplexessynthesischaracterizationsolutionspeciationredoxactivitycytotoxicityandmr2rnrinhibition